Plain-English overview
CJC-1295 DAC modifies growth-hormone-releasing hormone with a Drug Affinity Complex. That addition helps the compound bind albumin, extending exposure compared with short GHRH fragments.
How it is thought to work
Like natural GHRH, it signals the pituitary to release growth hormone. The DAC extension changes the pattern: instead of a brief pulse, researchers study a longer window of GH and downstream IGF-1 activity.
Research interest areas
- Sustained GH support
- Lean-mass research
- Recovery and tissue-maintenance models
What the research suggests
Early human pharmacology work supports durable GH and IGF-1 increases. That same long action is also the main caution: effects do not fade quickly once the signal is active.